Top 50 Biotech VC (Venture Capital) Funds in Italy in May 2025
A list of 50 VC (Venture Capital) funds that invest in Biotech startups based in Italy. We rank investors based on the number of investments they made in Biotech companies from Italy. We update this investor list every month.Top 50 Biotech VC (Venture Capital) Funds in Italy in May 2025
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- France, United States, United Kingdom
Portfolio highlights
- Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
- Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
- Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more
Investment focus
- Software, E-Commerce, Health Care
- Seed, Angel, Series A
- Italy, United States, United Kingdom
Portfolio highlights
- ALKemist Bio — ALKemist Bio provides cell treatment to cancer patients.
- Rubedo Life Sciences — Rubedo Life Sciences is the Premier Longevity Company. Rubedo discovers and develops medicines to keep you biologically young.
- Restorative Neurotechnologies — Siamo un'azienda di dispositivi medicali certificati per la riabilitazione cognitiva ed il trattamento di disturbi cognitivi post ictus.
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more
Investment focus
- Software, Health Care, Information Technology
- Seed, Series A, Funding Round
- Italy, United States, United Kingdom
Portfolio highlights
- Tundr — Tundr offers smartcard to companies for sustainable mobility.
- Genius4U — Genius4U offers washing, sewing, registered mail, shipping, and parcel delivery services. They provide physiotherapist massager, osteopath, nutritionist, hairdresser, beautician, and psychologist services. They also provide professional babysitting services.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- Italy, Switzerland, United States
Portfolio highlights
- TES Pharma —
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
- Valo Therapeutics — Valo Therapeutics is an immunotherapy company that is developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The Valo Tx platform, PeptiCRAd (Peptide-coated Conditionally Replicating Adenovirus), was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. It turns oncolytic adenovirusesinto targeted tissue specific cancer vaccines without the need to generate and manufacture multiple genetically modified viruses. The company is also developing PeptiENV, among other neoantigen strategies, in collaboration with Professor Cerullo. PeptiENV is expected to improve the therapeutic response to enveloped oncolytic viruses in the treatment of multiple forms of cancer.
Vertis is a dynamic and independent investment management company authorised by Bank of Italy. It manages five closed-end funds for qualified investors by participating in research projects, spin-offs, startups and PMI and deals with the investments of the innovative Made in Italy.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Seed, Series A, Funding Round
- Italy, United States
Portfolio highlights
- Radical Storage — Find your closest luggage storage and enjoy your journey until the very end!
- Focoos AI — Focoos reshapes computer vision with ultra-efficient models that drive down costs, automate hardware integration, and ensure peak performance on any device, while promoting sustainability.
- TimeFlow — TimeFlow is a software that acts as a B2B marketplace dedicated to the technical and managerial consulting sector.
A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more
Investment focus
- Biotechnology, Software, Information Technology
- Seed, Funding Round, Series A
- Italy, United Kingdom, France
Portfolio highlights
- Lumai — Lumai delivers fully optical computing for a quicker, smarter and more sustainable world. Lumai power the revolution of fully optical computing by working at the nexus of photonics and machine learning.
- Mediaire — mediaire supports radiologists with AI-based tools for MRI reporting. This enables them to make a more accurate and objective assessment even faster.
- Sparrow Quantum — Sparrow Quantum, a global leader in quantum photonic chip technology. Explore innovative solutions driving advancements in quantum computing, communication, and beyond. Stay ahead with cutting-edge technologies shaping the future.
Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Funding Round, Series A, Seed
- Italy, United States, United Kingdom
Portfolio highlights
- KLISBio — KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more
Investment focus
- Health Care, Medical, Medical Device
- Funding Round, Series A, Series B
- Italy, United States, Spain
Portfolio highlights
- GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
- Renovacor — Renovacor is a preclinical‑stage biopharmaceutical company focused on developing transformative gene therapy‑based treatments for cardiovascular disease.Renovacor’s lead program is a recombinant adeno-associated virus (AAV)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associatedathanogene 3 (BAG3) gene.Dilated cardiomyopathy is a condition affecting over 3 million patients in the US and growing steadily. Many patients develop DCM due to ischemic heart disease. Recently subpopulations have been identified that develop DCM due to mutations in specific genes that have been shown to result in the development of DCM. One of these specific genes is the BAG3 gene. The prevalence of disease‑causing BAG3 haploinsufficiency is estimated at approximately 35,000 individuals in the United States, representing an orphan disease by FDA guidelines. It is estimated a similar number of DCM patients with BAG3 mutations exist in Europe. These patients are typically younger and progress to end-stage heart failure sooner than patients with ischemic heart disease. Currently, DCM patients with a BAG3 mutation are treated with standard of care for heart failure. Despite improvements in pharmacotherapy and care, the five‑year survival of a patient with DCM is only 50%. The development of a BAG3 gene replacement therapy for patients with DCM that carry BAG3 mutations could potentially prevent the progression of disease in this otherwise healthy population of young adults.
- BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.
Green Arrow Capital is an independent financial group specializing in alternative investments across Europe. They represent a one-of-a-kind platform, capable of connecting the financial system with the real economy through the management of private equity, private debt, infrastructure, and special credit situation funds as well as thematic fundssuch as microfinance and funds of funds that are currently under management. Their team has a successful track record in asset management, investment banking, industry sectors, technology startups, management consulting, renewable energy, and has government and regulatory experience. Their group is mainly composed of investment, asset management, and financial advisory companies. Their aim is to create a solid financial platform to launch and manage investment funds dedicated to alternatives and to the real economy.
Show more
Investment focus
- Health Care, Biotechnology, Manufacturing
- Funding Round, Seed, Series A
- Italy, United Kingdom
Portfolio highlights
- Cogisen — Cogisen develops artificial intelligence solutions. It offers SENCOGI, an eye-tracking software for smartphones/mobile phones. Chiara Passacantilli and Christiaan Erik Rijnders founded Cogisen in 2009. Its headquarters is in Naples in Italy.
- Directa Plus — Directa Plus is a nanotechnology company, manufactures nanoparticles.
- Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
A11-Venture investe nel capitale di startup innovative nei settori della robotica, automazione, meccatronica, cleantech, web e IT. Facilita la nascita e lo sviluppo di business innovativi globali per il futuro dell'economia locale. Contribuisce a costruire aziende, lavoro qualificato, brevetti, innovazione capaci di rilanciare e riportareinvestimenti e risorse sul territorio. I soci di A11 Venture credono fermamente nell’innovazione grazie a ciò è possibile crescere per linee esterne diversificando i propri investimenti, grazie ad un portafoglio di imprese, con una forte risk mitigation derivante dalla gestione professionale di tutti processi:
scouting, team building, investimenti, management degli investimenti, accelerazione e disinvestimento.
Show more
Investment focus
- Biotechnology, Medical Device, Health Care
- Seed, Pre-Seed, Series A
- Italy, United States
Portfolio highlights
- Reefilla — Reefilla EV charging services: recharge your car anywhere, anytime
- Endostart — Endostart development and manufacturing of a new generation medical devices for gastrointestinal endoscopy.
- Neuron Guard — Neuron Guard, recognized as the best European startup in HEALTH category (Startup Europe Awards - SEUA 2017), is developing a life-saving medical device that aims to become the standard of care for Targeted Temperature Management (TTM) therapy. Every 7 seconds around the world a person suffers of Acute Brain Damage because of CardiovascularDiseases (CVD) and Traumatic Brain Injury (TBI). They are the most costly and prevalent killers in the last 15 years (15 million deaths by CVD in 2015), and the leading cause of disability (the global incidence rate of TBI is 200 per 100k people per year). WHO estimated a global expenditure of $ 330 billion in 2015, but it is going to increase sharply: $ 4 trillion in 2025 - including premature death, disability, and health care costs - just for CVD in LMICs. Temperature is a vital body parameter. It regulates all cellular functions so its management is essential for the good outcome of patients in several medical conditions such as cardiac arrest, stroke, traumatic brain injury, neuro and cardiac surgery, epilepsy, migraine and oncology. Regulating body temperature at a desired level makes all other treatments more effective. The most modern medical approach is the target temperature management, where physicians try to maintain the most favourable temperature for the patient for up to 24-36 hours, preventing excessive warming (fever) or cooling.Our device is a targeted temperature management system composed by a THERAPEUTIC COLLAR POWERED BY A SMART CONTROL UNIT (the size of a small briefcase). The collar transforms the neck into a natural heat exchanger exploiting several physiological and anatomical characteristics of the human body. It is quicker to act on brain tissue but can also function as total body temperature adjusting device if required. A disposable protective shield makes cleaning the collar after each use simple while featuring an optimal safety profile both in term of pathogens and allergens. The control unit collects all the data of the treatment and transmits them to the Emergency Response System. Our mission is to improve the safety of patients on the roadside, at home or in the workplace, and to reduce the costs of chronic care. In fact, Neuron Guard aims to be the only device that can be used in every circumstance, inside and outside the hospital, and allow the user to fully manage the temperature of the patient warming and cooling as necessary. Our vision is to have a Neuron Guard kit in every public place just like the Automatic External Defibrillator (AED) to empower bystanders to immediately react in case of emergency. Under this perspective our device becomes a connected-intelligent platform that takes care of the patient, connects the scene with the Emergency Response System transmitting vital data to improve the readiness and effectiveness of professional intervention.The device is patented in Italy, USA and China. We have made several prototypes in collaboration with Italian and English companies, such as Tecno Elettra Impianti and TWI, tested it in laboratory and published the experimental results on the NeuroCritical Care Journal. We have also conducted a GAP Analysis with another English consulting firm (CDP) and we are testing the human prototype internally. We are seeking to raise 2.5M€ to complete the pre-industrialization, with design and construction of the human device for the pilot trial, finalized the regulatory clearance and launch it into the market in 2019.
Investment fund specialized in sustainable technologies from universities and public research organizations, start-ups, spin-offs, and entrepreneurs.
Show more
Investment focus
- Biotechnology, Water, Manufacturing
- Series A, Seed, Funding Round
- Italy, Ireland, United Kingdom
Portfolio highlights
- WembraneX — WembraneX's goal is to make wastewater treatment facilities more cost-effective by introducing a new class of anti-fouling and anti-biofouling membranes.
- Naturbeads — Naturbeads creates biodegradable, sustainable and cost competitive cellulose microbeads to replace currently used microplastics.
- Valuematic — Valuematic realizza soluzioni per il trattamento e gestione dei dati favorendo il miglioramento nei processi organizzativi e informativi di aziende ed enti.
INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers.
Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.
Show more
Investment focus
- Medical, Health Care, Privacy
- Seed, Angel, Funding Round
- Italy
Portfolio highlights
- CellPly — Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing theability to monitor the clinical response to these treatments.Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.
- GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
- Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Atlante Ventures is a leading Italian VC fund, operated by IMI Fondi Chiusi SGR, part of Intesa Sanpaolo Group.
Show more
Investment focus
- Software, Biotechnology, Hardware
- Funding Round, Seed, Series A
- Italy, United States, Israel
Portfolio highlights
- treet — Treet helps brands launch fully-branded recommerce sites where customers can buy & sell items from each other.
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Eureka! is the first independent Italian venture capital Asset Management company exclusively focused on deep tech investments
Show more
Investment focus
- Nanotechnology, Renewable Energy, Medical Device
- Seed, Funding Round, Pre-Seed
- Italy
Portfolio highlights
- Novac — Progettiamo supercondensatori da affiancare alle batterie, per incrementare performance ed efficienza dei veicoli elettrici.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
- BeDimensional — New Material Solution
Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.
Show more
Investment focus
- Health Care, E-Commerce, Information Technology
- Seed, Series A, Series B
- Italy, Switzerland, United Kingdom
Portfolio highlights
- Stema — It serves as a platform for hiring engineers
- Approxima — Approxima medical is developing a novel treatment for patients with tricuspid valve regurgitation
- Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Seed, Series A, Series B
- Italy, United Kingdom
Portfolio highlights
- NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
- ALKemist Bio — ALKemist Bio provides cell treatment to cancer patients.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation.
Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
Show more
Investment focus
- Software, Medical, Health Care
- Series A, Funding Round, Seed
- Italy, United States, United Kingdom
Portfolio highlights
- Ecomate — The ESG Rating platform for every company
- BigProfiles — A deep understanding of customers let a company tailor marketing campaigns and CRM strategies, but companies have only basic data about customers (e.g. gender or age). External data sources like Social Networks, Public Registries and Socio-Demographic data contain rich information about billions of people, like job titles, levels of education,interests and habits.BigProfiles is a Customer Intelligence SAAS that leverages external information about persons to enrich customer profiling: it can profile a company's customers with previously unknown information about them. Thanks to its Identity Resolution algorithm (the result of a PHD), it identifies a person’s information scattered among external sources.Through this technology, BigProfiles provides customer base analytics and behavior predictions: using Artificial Intelligence on enriched profiles allows to predict churn, fraud and willingness to buy.
- Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
Intesa Sanpaolo is a banking group that specializes in wealth management, protection, advisory, and digital orientation. Their products and services include accounts, cards, loans, mortgages, insurance, digital payments, retirement planning, investments, and consulting. It was founded by the merger of Banca Intesa and Sanpaolo IMI.
Show more
Investment focus
- Energy, Renewable Energy, Financial Services
- Debt Financing, Post-IPO Debt, Convertible Note
- Italy, United Kingdom, United States
Portfolio highlights
- Currenta — Currenta provides services in the area of chemistry, pharmacy, environment, fire technology and consulting.
- Hippocrates — Hippocrates operates a pharmacy platform with a network of over 120 owned pharmacies concentrated in central and northern Italy. Since its foundation, it has approached the pharmacy sector with an industrial and long-term logic. The company was founded in March 2018 by Davide Tavaniello and Rodolfo Guarino, co-CEOs of Hippocrates.
- Recurrent Energy — As a leading provider of distributed solar power, Recurrent Energy is overcoming the barriers to widespread solar adoption, making renewable energy a practical choice for today's large scale energy users. They are a developer and owner of locally-sited solar power systems, selling clean electricity to their customers worldwide at competitiverates via a Power Purchase Agreement (PPA) or Feed-in Tariffs (FiT). In return, their utility, commercial, and government customers achieve energy independence, predictable pricing, and enhanced sustainability.
Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250million under management.
Show more
Investment focus
- Health Care, Medical, Medical Device
- Series B, Series A, Series C
- Italy, Switzerland, United Kingdom
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Relief — RELIEF s.r.l. aims at introducing on the market miniaturized devices for the treatment of urinary incontinence. In particular, the company proposes a technology that is simple, highly innovative, unisex, effective, low-cost and acceptable from the patient viewpoint.
- Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more
Investment focus
- Health Care, Wellness, Medical
- Seed, Funding Round, Pre-Seed
- United States, Canada, United Kingdom
Portfolio highlights
- AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
- JETSWEAT — Jetsweat is a well-being platform that helps organizations engage populations to live healthier lives. We partner with forward-thinking employers, health plans and health systems to set a new standard for holistic and preventative care, driving better outcomes through engaging journeys, personalized programming from exclusive provider ecosystem,and dedicated white-label software.
- Hidoc Consult — Hidoc Consult: Boost your well-being with free consultations, 24/7 access to quality healthcare, complete privacy, user-friendly, and a trusted network of HCPs
Kering Ventures is the venture investment arm of the Kering Group, acquiring minority holdings in startups.
Show more
Investment focus
- Biotechnology, Interior Design
- Series A
- Italy
3LB Seed Capital is not an alternative to start-ups incubators and accelerators, rather acts as a complementary reality that helps to enhance your project in terms of attractiveness for the investor and venture capital market.As investors they are the first willing to know if your project has what it takes to grow successfully. If they areconvinced of your potential, they are ready to bet on you, by joining you and helping you to develop your project.3LB Seed Capital does not provide a percentage of equity in exchange for accompanying activities, but relies exclusively on a premium at the time of its first direct investment in your company.
Show more
Investment focus
- E-Commerce, Software, Information Technology
- Seed, Pre-Seed, Series A
- Italy, United States, United Kingdom
Portfolio highlights
- YoAgents — Yo Agents nasce dalla unione delle competenze di ogni singolo founder messe a fattor comune per creare un sales hub innovativo.
- Botsociety — Your conversational design suite. Design and prototype your next chatbot or voice assistant. Create a mockup of your project on Messenger, Slack, Google Assistant, Alexa and more. The next generation design solution for chatbots and voice.
- Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.
European Circular Bioeconomy Fund invest and partner with entrepreneurs to accelerate late-stage circular bioeconomy companies.
Show more
Investment focus
- Biotechnology, AgTech, Agriculture
- Series B, Series A, Series C
- The Netherlands, France, Italy
Portfolio highlights
- OroraTech — From safeguarding forests and ecosystems to protecting communities and critical assets, OroraTech's advanced technology and reliable insights address challenges, mitigate risks, and drive meaningful impact.
- Elicit Plant — We work with farmers around the world to meet the challenges of climate change and the impact of water scarcity on field crops.
- watttron — Watttron invents a revolutionary heating system that can heat up surfaces heterogeneously.Watttron develops an innovative heating technology that can be used in various industrial processes. It is superior to current heating systems in many ways and offers a number of advantages. On the following pages, you will find information about possibleapplications and opportunities.The company is located in the Technologie- und Gründerzentrum Freital – a technology and start-up center on the outskirts of Dresden, the state capital of Saxony.
Angel group focuses on biotech
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Seed
- Italy
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
- Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.
Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.
Show more
Investment focus
- Software, Health Care, Artificial Intelligence
- Seed, Pre-Seed, Grant
- Italy, United Kingdom
Portfolio highlights
UniCredit (formerly UniCredito) is an Italian global banking and financial services company. Its network spanning 50 markets in 20 countries, with more than 9,000 branches and over 148,000 employees. Its strategic position in Western and Eastern Europe gives the group one of the region's highest market shares.
Show more
Investment focus
- Energy, Manufacturing, Financial Services
- Debt Financing, Post-IPO Debt, Funding Round
- Italy, Germany, Sweden
Portfolio highlights
- La Doria — La Doria is a producer and sells tomato derivatives, ready sauces, preserved legumes, fruit juices, and beverage products. They offer products that include boiled legumes, baked beans, red kidney beans, carrots, ready-made soups and stews, and canned pasta in tomato sauce.
- Unifiber — Unifiber is a broadband service company that focuses on the creation of passive access fiber optic networks.
- ambrogio transporti — ambrogio transporti is a intermodal transportation company.
Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.
Show more
Investment focus
- Biotechnology, Therapeutics, Medical
- Series B, Series A, Funding Round
- United States, Italy, United Kingdom
Portfolio highlights
- NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
- Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
- On Target Laboratories — ON TARGET LABORATORIES discovers and develops fluorescent markers to target and illuminate cancer during surgery so it can be removed more completely.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more
Investment focus
- Biotechnology, Health Care, Energy
- Debt Financing, Post-IPO Debt, Funding Round
- France, Germany, The Netherlands
Portfolio highlights
- UP Catalyst — UP Catalyst produces sustainable carbon nanomaterials and graphite for the green energy storage industry.
- Sidekick Health — Our mission is to develop and deliver effective personalized digital therapeutics that prevent suffering and add millions of quality life years to people around the world. Our multi-chronic digital care platform allows us to scale the production of clinical treatments across major chronic diseases.
- Heura Foods — Heura is a plant based startup founded by food activists Marc Coloma and Bernat Añaños in April 2017. Its mission is to create solutions that will leave the current food system obsolete and accelerate the transition to a world where animals are out of the equation. Their Mediterranean culinary heritage is reflected on their products: clean label,high nutritional values and taste.
Scopri i servizi bancari e finanziari di Banco BPM: conti, mutui, carte, prestiti, assicurazioni, trading e tanto altro. Per privati e imprese.
Show more
Investment focus
- Manufacturing, Product Design, Energy
- Debt Financing, Post-IPO Debt, Pre-Seed
- Italy, United States, Spain
Portfolio highlights
- NextChem — NextChem is the green chemistry subsidiary of Maire Tecnimont, an Italian multinational company specializing in engineering, technology, and energy. NextChem focuses on the energy transition by developing and deploying innovative solutions for sustainable industrial processes. It aims to accelerate decarbonization and promote the circular economythrough advanced technologies.
- Maire Tecnimont — We are enablers of innovation, working alongside businesses to develop sustainable technologies and design integrated solutions that inspire energy transition.
- Garofalo Health Care — Garofalo Health Care SpA is a major group in Italy in the authorized private healthcare sector and the only Italian firm listed on the Star division of the Italian Stock Exchange in the healthcare industry.
Launch Tennessee provides startup resources to entrepreneurs, including capital sources, mentorship, accelerators, entrepreneurship training and more
Show more
Investment focus
- Software, Health Care, Medical
- Grant, Seed, Series A
- United States, China, Italy
Portfolio highlights
- DAXOR — DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential totransform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility.The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.
- Preteckt — Preteckt's AI software predicts & prevents breakdowns in buses & coaches. Reduce costs, maximize uptime, & extend vehicle life
- Daily Crunch — Daily Crunch is an offline and online store that offers cherry-berry nuts, cacao sea salt, and sprouted almonds products.
Planet A supports founders tackling the world's largest environmental problems. We're building the economy our planet needs.
Show more
Investment focus
- Software, Manufacturing, Renewable Energy
- Seed, Series A, Funding Round
- Germany, United Kingdom, Italy
Portfolio highlights
- PULSETRAIN — Pulsetrain is the only company with a driving Multilevel demonstrator. Tech that moves, not just talks. AC Multilevel for construction machines. Ultra-high-power DC for next-gen vehicles. Game-changing. Let’s roll.
- Arsenale Bioyards — Arsenale is making industrial-scale biomanufacturing via precision fermentation economically viable for the very first time.
- C1 Green Chemicals — C1 develops climate friendly chemical production processes via computer simulation. Our first product is green methanol. Circular carbon chemistry reducing CO2.
Blue Ocean Finance S.p.A is a financial consulting firm focusing on Italian startups and innovative SMEs.
The company’s aim is to assist enterprises in achieving their objectives of growth by developing a tailored financial strategy, obtaining new capital and advising them during extraordinary business operations.
Funded in Rome in 2018, BlueOcean Finance is well known for its expertise in Corporate Finance, Banking and Financial Advisory.
Show more
Investment focus
Portfolio highlights
- Genoa Instruments — Genoa Instruments is an innovative startup dedicated to transforming the field of biomedical and health research through advanced super-resolution optical microscopy. Our groundbreaking optical microscope uniquely integrates spatial and temporal super-resolution for structural and functional imaging in living samples with unprecedented detail. Ourmission is to make high-resolution imaging accessible to all, fostering scientific discovery and advancing healthcare research.
Deep Blue Ventures is an international holding company that acquires, manages, and scales the next generation of online brands.
Show more
Investment focus
- Biopharma, Life Science, Biotechnology
- Funding Round
- Italy
Portfolio highlights
- Genoa Instruments — Genoa Instruments is an innovative startup dedicated to transforming the field of biomedical and health research through advanced super-resolution optical microscopy. Our groundbreaking optical microscope uniquely integrates spatial and temporal super-resolution for structural and functional imaging in living samples with unprecedented detail. Ourmission is to make high-resolution imaging accessible to all, fostering scientific discovery and advancing healthcare research.
Investment focus
Portfolio highlights
- Genoa Instruments — Genoa Instruments is an innovative startup dedicated to transforming the field of biomedical and health research through advanced super-resolution optical microscopy. Our groundbreaking optical microscope uniquely integrates spatial and temporal super-resolution for structural and functional imaging in living samples with unprecedented detail. Ourmission is to make high-resolution imaging accessible to all, fostering scientific discovery and advancing healthcare research.
RECOMEC operates as a venture capital firm that primarily invests in the healthcare sector.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Funding Round
- Italy
Portfolio highlights
- CellPly — Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing theability to monitor the clinical response to these treatments.Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.
Atlas Venture is an early-stage venture capital firm that creates and invests in biotech startup companies led by promising entrepreneurs focusing on life sciences innovation. Its seed-led venture creation strategy rigorously selects and focuses investment on compelling opportunities to build scalable businesses and realize value.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, United Kingdom, Canada
Portfolio highlights
- Judo Bio — Judo Bio is pioneering oligonucleotide medicines delivered to the kidney, opening the way for new treatments for systemic and renal diseases.
- Be Biopharma — Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.
- Trace Neuroscience — Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients with neurodegenerative illnesses.
Evotec is a global biotechnology company committed to advancing drug discovery & development together with our partners for medicines that matter.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Germany, France
Portfolio highlights
- Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
- Aeovian Pharmaceuticals — Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.
Index Ventures is an international venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security.
Show more
Investment focus
- Software, E-Commerce, Internet
- Series A, Series B, Seed
- United States, United Kingdom, France
Portfolio highlights
- Taktile — Taktile's no-code platform enables you to easily build automated decision flows and iterate on them in a data-driven way leveraging backtests and A/B testing.
- Cartesia — Cartesia provides real-time multimodal intelligence for all devices. Its objective is to develop the next generation of AI: pervasive, interactive intelligence that operates everywhere.
- Dorsia — Dorsia is a members-only platform that offers reservations at in-demand restaurants in major cities. The platform utilizes technology to enhance experiences for both operators and members, ensuring smooth booking without stress. Dorsia operates in various cities, including Miami, Los Angeles, Dubai, and San Francisco, making it a versatile choicefor food enthusiasts.
Founded in 2007, with offices in Milan, Munich, London and Paris Ambienta is a leading asset manager entirely focused on investments driven by environmental sustainability key drivers, Resource Efficiency and Pollution Control
Show more
Investment focus
- Manufacturing, Energy, Renewable Energy
- Private Equity, Funding Round, Series A
- Italy, United Kingdom, Germany
Portfolio highlights
- Caprari — Caprari design, production, and distribution of centrifugal pumps and motors for the integrated water cycle.
- Nactarome — Nactarome are manufacturer and producer of natural food flavoring components, colours, and ingredients sector.
- Maccaferri — Maccaferri provides tailor-made design and development solutions for complex civil, geotechnical and environmental engineering works all around the word.
DEEP BLUE VENTURES
Venture Capital Fund
DEEP BLUE VENTURES
DBV Deep Blue Ventures is our first Venture Capital fund
DBV is an early stage deep tech fund, investing in outstanding deep technologies, and people able to harnessing them to great global success.
Deep Blue Ventures
Show more
Investment focus
- Biotechnology, Medical Device, Artificial Intelligence
- Seed
- Italy
Portfolio highlights
- INTA Systems — Nanotech and artificial intelligence for biomolecular analysis
Riso Gallo is a rice producer specializing in processing, and distributing of risotto rice to consumers around the world.
Show more
Investment focus
- Biotechnology, Interior Design
- Funding Round
- Italy
Portfolio highlights
- MOGU — By employing one of its finest technologies, mycelium, Mogu delivers responsible products for interior design. Mycelium design with Mogu.
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Seed, Funding Round, Series A
- United Kingdom, Italy, Germany
Portfolio highlights
- ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
- Flynotes — Flynotes is a digital software platform helping dentists deliver personalised patient care
- QV Bioelectronics — Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours.
Arieli Capital is an investment firm dedicated to advancing cutting-edge technology by making strategic investments in top tech sectors
Show more
Investment focus
- Analytics, Biotechnology, Manufacturing
- Seed
- Italy, Israel
Portfolio highlights
- Diamante — Diamante is a company that develops and manufactures autoimmune disease diagnosis devices using nanomaterials. It exploits plants as bioreactors for the sustainable production of nanoparticles based on modified plant viruses that are used in developing new tools. Diamante was founded in 2016 and is headquartered in Verona, Italy.
- Terrific — We bring Brands & Influencers together to recreate the online shopping experience by empowering the story of your brand.
V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life science companies. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biotech, pharmaceutical and agriculturalsectors.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Seed
- Belgium, France, United Kingdom
Portfolio highlights
- AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
- Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
- Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
The official website of the European Commission, providing access to information about its political priorities, policies and services
Show more
Investment focus
- Software, Biotechnology, Health Care
- Grant, Seed, Pre-Seed
- Spain, France, Germany
Portfolio highlights
- ENZIDIA — We crack the fundamental bottlenecks of enzyme engineering with unprecedented screening and data collection capacity
- ETHRIS — About Ethris Ethris has paved a new path from genes to therapeutic proteins using its proprietary, non-immunogenic messenger RNA technology platform to discover, design and develop innovative therapies. With more than a
- PhotonHub Europe — PhotonHub Europe is an digital innovation hub for photonics.
FM Management is a private equity firm focused on the growth and development of small- and medium-sized companies.
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Series A
- Italy
Portfolio highlights
- Erydel — Based in Urbino, EryDel has developed and patented a technology for drug delivery of pharmacological agents through erythrocytes (red blood cells). This process allow to easily load red blood cells with drugs, proteins, contrasting agents for diagnostic purposes, nanoparticles etc. that can be progressively released into the patient body thusallowing an increased efficacy of the therapy and a reduction of collateral effects. The benefit is extremely significant particularly for chronic pathologies that requires continuous daily treatments for patients which could be substituted by monthly transfusion of blood loaded with specific therapeutic agents. Currently, the solution has been tested by several patients for the treatment of Inflammatory Bowel Diseases (IBDs) such as ulcer colitis and Crohn disease. The company can provide a complete support for the drug delivery process including a specific device for the erythrocytes loading ("Red Cell Loader"), and disposable kits.
- Datamars — Datamars was founded in 1988 as a joint venture between the technology companies Datalogic and Audemars to develop, design and manufacture state-of-the-art RFID solutions. The company quickly established itself as a world leader in RFID solutions for the animal and textile identification markets.
GCM Group is an investment firm.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Seed
- Italy
Portfolio highlights
- GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
Istituto Nazionale Biostrutture e Biosistemi is a platform for biostructures and biosystems that represent the intersection and the synthesis between the life sciences and physical sciences.
Show more
Investment focus
- Wellness, Health Care, Biotechnology
- Corporate Round
- Italy
Portfolio highlights
- Adamas Biotech — More than a decade of basic research in the field of botanical function-specific antioxidants. The nutraceutical solutions proposed to stem from a patented protected technology.
Utopia is a venture capital firm that is dedicated to life sciences.Utopia SIS is an investment company specializing in healthcare and biomedical research, promoted and owned by the Golinelli Foundation.Utopia was established with the aim of bridging this gap, through investments in high-potential start-ups operating in the Life Sciencessector.
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Seed
- Italy
Portfolio highlights
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
PortfolioTeam London | City Road 152-160, EC1V 2NX Roma | Via Giovanni Battista Morgagni, 3, 00161
Show more
Investment focus
- B2B, E-Commerce, Food and Beverage
- Seed, Pre-Seed, Series A
- Italy
Portfolio highlights
- Macai — Macai offers thousands of high-quality products delivered at your doorstep in a few minutes.Macai is the first Italian company active in the Q-commerce space. Founded by Giovanni Cavallo, serial entrepreneur with a deep background in food delivery, the project is now live in Milan and Turin. Compared to other players in the industry, Macai ismore focused on providing a wider offer than on the speed variable. We aim at building an online full grocer, with more than 7000 skus delivered in less than 45 minutes.
- GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
- Insoore — Insoore is a platform that helps insurance companies to improve the claims management process, thanks to on-demand photographic inspections and damage estimates provided by a community of experts.
Investors by industry
Impact
Biotech
Gaming
FinTech
Google
Energy
Proptech
Marketplace
Consumer
Hardware
Artificial intelligence
Health Care
Climate
Community
EdTech
Sustainability
Venture Capital
Clean Energy
Real Estate
Financial Services
Video Games
B2B
Education
Publishing
Finance
Social Media
Medical
Internet
Manufacturing
eSports
Construction
Digital Media
Art
Local
Sports
Music
Enterprise Software
Social Network
Wellness
Email
Franchise
Android
Mobile
Legal
Mobile Advertising
Platforms
Cannabis
Hospitality
Biotechnology
Travel
Fitness
Recruiting
Automotive
Medical Device
Social
Crowdfunding
Wine And Spirits
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
Food and Beverage
Beauty
Infrastructure
LGBT
Web3
Photography
Retail
Big Data
Organic Food
Payments
Fashion
Oil and Gas
Film
Life Science
Theatre
Renewable Energy
Non Profit
SaaS
Sporting Goods
Celebrity
Restaurants
Social Impact
Software
Cryptocurrency
Agriculture (agtech)
Machine Learning
Media (entertainment)
Blockchain
Facebook
Investors by country
United Kingdom
Germany
India
United States
Ireland
South Korea
Canada
Australia
New Zealand
Middle East
Oceania
Europe
Asia
South Africa
Armenia
Brazil
Qatar
Indonesia
Spain
China
Saudi Arabia
Sri Lanka
Vietnam
Africa
LATAM
Japan
Singapore
Finland
Estonia
Hungary
Ethiopia
Mali
Hong Kong
Mexico
Liberia
Israel
Philippines
Malaysia
Italy
Lithuania
Liechtenstein
Kuwait
Norway
Morocco
Myanmar
Lebanon
Mauritius
Peru
Jersey
Panama
Malta
Nicaragua
Sweden
El Salvador
Uruguay
Portugal
Zambia
Ukraine
Uzbekistan
Senegal
Seychelles
Venezuela
Tajikistan
Taiwan
Serbia
Uganda
Sierra Leone
Turkey
Thailand
Tunisia
San Marino
Rwanda
Puerto Rico
Poland
Russian Federation
Tanzania
Slovenia
Zimbabwe
Togo
Dominican Republic
Azerbaijan
Nigeria
Bahamas
Namibia
Iceland
Iraq
United Arab Emirates
Jamaica
Honduras
Isle of Man
Bolivia
Luxembourg
Albania
Pakistan
Georgia
Grenada
Romania
Jordan
Argentina
Bangladesh
Egypt
Ecuador
Denmark
France
Faroe Islands
Ghana
Croatia
Gibraltar
Bulgaria
Chile
Belize
Barbados
Costa Rica
Greece
Belgium
Bahrain
Belarus
Bermuda
Czech Republic
Algeria
Kenya
Kazakhstan
Cayman Islands
Cambodia
Austria
Oman
Cyprus
Latvia
Cameroon
Switzerland
Guatemala
Colombia
Marshall Islands
VC (Venture Capital) Funds in Italy by industry
Restaurants
Transportation
Financial Services
Food and Beverage
Venture Capital
Cryptocurrency
Education
Finance
Big Data
Payments
Wine And Spirits
Organic Food
Medical
Medical Device
Social Media
Wellness
Internet
Manufacturing
Digital Media
Social Network
Art
Mobile
Music
Local
Android
Blockchain
Construction
Sports
Software
Enterprise Software
CleanTech
Travel
Hospitality
InsurTech
Automotive
Platforms
Biotechnology
Recruiting
FinTech
Consumer
Health Care
Energy
Biotech
EdTech
Climate
Sustainability
Impact
Proptech
Marketplace
Community
Artificial intelligence
Hardware
Gaming
Mobile Apps
Fashion
Social
Retail
Beauty
Web3
B2B
Life Science
Publishing
Media (entertainment)
Real Estate
Agriculture (agtech)
Fitness
Social Impact
Machine Learning
Renewable Energy
SaaS
Enterprise
Oil and Gas